These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9566226)

  • 41. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays.
    Guimond C; Trudel N; Brochu C; Marquis N; El Fadili A; Peytavi R; Briand G; Richard D; Messier N; Papadopoulou B; Corbeil J; Bergeron MG; Légaré D; Ouellette M
    Nucleic Acids Res; 2003 Oct; 31(20):5886-96. PubMed ID: 14530437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes.
    Nazari-Vanani R; Vais RD; Sharifi F; Sattarahmady N; Karimian K; Motazedian MH; Heli H
    Acta Trop; 2018 Sep; 185():69-76. PubMed ID: 29733808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leishmania sp. isolated from human cases of cutaneous leishmaniasis in Brazil characterized as Leishmania major-like.
    Silva Sde O; Wu AA; Evans DA; Vieira LQ; Melo MN
    Acta Trop; 2009 Dec; 112(3):239-48. PubMed ID: 19660430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.
    Al-Mohammed HI; Chance ML; Bates PA
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3274-80. PubMed ID: 16048936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The P-glycoprotein-related gene family in Leishmania.
    Légaré D; Hettema E; Ouellette M
    Mol Biochem Parasitol; 1994 Nov; 68(1):81-91. PubMed ID: 7891750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aporphine alkaloids from Guatteria spp. with leishmanicidal activity.
    Montenegro H; Gutiérrez M; Romero LI; Ortega-Barría E; Capson TL; Rios LC
    Planta Med; 2003 Jul; 69(7):677-9. PubMed ID: 12898429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro.
    Berman JD; Chulay JD; Hendricks LD; Oster CN
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):459-65. PubMed ID: 7081539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leishmaniasis in the major endemic region of Plurinational State of Bolivia: Species identification, phylogeography and drug susceptibility implications.
    Bilbao-Ramos P; Dea-Ayuela MA; Cardenas-Alegría O; Salamanca E; Santalla-Vargas JA; Benito C; Flores N; Bolás-Fernández F
    Acta Trop; 2017 Dec; 176():150-161. PubMed ID: 28751163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Metacyclics of Leishmania mexicana in the hypopharynx of Lutzomyia youngi experimentally infected].
    Rojas E; Scorza JV
    Parassitologia; 1991 Dec; 33 Suppl():493-500. PubMed ID: 1841249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leishmania species: evidence for transglutaminase activity and its role in parasite proliferation.
    Brobey RK; Soong L
    Exp Parasitol; 2006 Oct; 114(2):94-102. PubMed ID: 16620812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Four cutaneous leishmaniosis case resistant to meglumine antimoniate treatment].
    Polat E; Kutlubay Z
    Turkiye Parazitol Derg; 2014; 38(3):177-80. PubMed ID: 25308455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The activity of nitrofurazone and furazolidone against Leishmania donovani, L. major and L. enriettii in vitro and in vivo.
    Neal RA; van Bueren J; Hooper G
    Ann Trop Med Parasitol; 1988 Oct; 82(5):453-6. PubMed ID: 2855778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tamoxifen Induces Apoptosis of Leishmania major Promastigotes in Vitro.
    Doroodgar M; Delavari M; Doroodgar M; Abbasi A; Taherian AA; Doroodgar A
    Korean J Parasitol; 2016 Feb; 54(1):9-14. PubMed ID: 26951973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemical Characterization, Antileishmanial Activity, and Cytotoxicity Effects of the Essential Oil from Leaves of Pluchea carolinensis (Jacq.) G. Don. (Asteraceae).
    García M; Scull R; Satyal P; Setzer WN; Monzote L
    Phytother Res; 2017 Sep; 31(9):1419-1426. PubMed ID: 28703380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting Leishmania major parasite with peptides derived from a combinatorial phage display library.
    Rhaiem RB; Houimel M
    Acta Trop; 2016 Jul; 159():11-9. PubMed ID: 26995695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of phosphoglycans in the susceptibility of Leishmania mexicana to the temporin family of anti-microbial peptides.
    Eggimann GA; Sweeney K; Bolt HL; Rozatian N; Cobb SL; Denny PW
    Molecules; 2015 Feb; 20(2):2775-85. PubMed ID: 25668079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heavy metal resistance: a new role for P-glycoproteins in Leishmania.
    Callahan HL; Beverley SM
    J Biol Chem; 1991 Oct; 266(28):18427-30. PubMed ID: 1680861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The therapy of cutaneous and mucocutaneous leishmaniasis].
    Blum J; Hatz C; Junghanss T
    Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1169-72. PubMed ID: 8076505
    [No Abstract]   [Full Text] [Related]  

  • 60. Leishmania spp.: proficiency of drug-resistant parasites.
    Natera S; Machuca C; Padrón-Nieves M; Romero A; Díaz E; Ponte-Sucre A
    Int J Antimicrob Agents; 2007 Jun; 29(6):637-42. PubMed ID: 17353113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.